Andreas Reinisch

Stem Cell Research Unit, Medical University of Graz, Austria

Affiliated withMedical University of Graz, Austria Medical University of Graz

Research Area

Biography

Andreas Reinisch has not added Biography.
If you are Andreas Reinisch and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 3	Year
Publication title Cited by 38	2009
Publication title Cited by 66	2009
Publication title Cited by 5	2023

Other Publications

Article	Year
Immune cells mimic the morphology of endothelial progenitor colonies in vitro. Stem cells (Dayton, Ohio)\| PubMed ID: 17395771	2007
Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application. Regenerative medicine\| PubMed ID: 17635045	2007
Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion\| PubMed ID: 17655588	2007
Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum. Tissue engineering. Part C, Methods\| PubMed ID: 18620484	2008
Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo. Blood\| PubMed ID: 19321860	2009
Platelet-derived growth factors for GMP-compliant propagation of mesenchymal stromal cells. Bio-medical materials and engineering\| PubMed ID: 20042793	2009
Replicative senescence-associated gene expression changes in mesenchymal stromal cells are similar under different culture conditions. Haematologica\| PubMed ID: 20053868	2010
Pro-angiogenic induction of myeloid cells for therapeutic angiogenesis can induce mitogen-activated protein kinase p38-dependent foam cell formation. Cytotherapy\| PubMed ID: 21128706	2011
Human dermis harbors distinct mesenchymal stromal cell subsets. The Journal of investigative dermatology\| PubMed ID: 22048731	2012
Increased Expression of Micro-RNA-23a Mediates Chemoresistance to Cytarabine in Acute Myeloid Leukemia. Cancers\| PubMed ID: 32093419	2020
A Dysregulated DNA Methylation Landscape Linked to Gene Expression in MLL-Rearranged AML. Epigenetics\| PubMed ID: 32114880	2020
Human extramedullary bone marrow in mice: a novel in vivo model of genetically controlled hematopoietic microenvironment. Blood\| PubMed ID: 22490334	2012
Oxygen sensing mesenchymal progenitors promote neo-vasculogenesis in a humanized mouse model in vivo. PloS one\| PubMed ID: 22970226	2012
Identification of an effective early signaling signature during neo-vasculogenesis in vivo by ex vivo proteomic profiling. PloS one\| PubMed ID: 23826172	2013
Placental mesenchymal stromal cells derived from blood vessels or avascular tissues: what is the better choice to support endothelial cell function? Stem cells and development\| PubMed ID: 25244528	2015
Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation. Blood\| PubMed ID: 25406351	2015
Autologous cell sources in therapeutic vasculogenesis: In vitro and in vivo comparison of endothelial colony-forming cells from peripheral blood and endothelial cells isolated from adipose t... Cytotherapy\| PubMed ID: 26669908	2016
Identification of the Human Skeletal Stem Cell. Cell\| PubMed ID: 30241615	2018
High GPR56 surface expression correlates with a leukemic stem cell gene signature in CD34-positive AML. Cancer medicine\| PubMed ID: 30848055	2019
TP53 mutated AML subclones exhibit engraftment in a humanized bone marrow ossicle mouse model. Annals of hematology\| PubMed ID: 32002654	2020
Sensitive and broadly applicable residual disease detection in acute myeloid leukemia using flow cytometry-based leukemic cell enrichment followed by mutational profiling. American journal of hematology\| PubMed ID: 32602117	2020
Micro-RNA-125a mediates the effects of hypomethylating agents in chronic myelomonocytic leukemia. Clinical epigenetics\| PubMed ID: 33407852	2021
EZH2 inactivation in RAS-driven myeloid neoplasms hyperactivates RAS-signaling and increases MEK inhibitor sensitivity. Leukemia\| PubMed ID: 33589750	2021
miR-23a mediates resistance to hypomethylating agents in myeloid neoplasms. Annals of hematology\| PubMed ID: 34291333	2021
Targeted regulation of transcription in primary cells using CRISPRa and CRISPRi. Genome research\| PubMed ID: 34407984	2021
Fasting improves therapeutic response in hepatocellular carcinoma through p53-dependent metabolic synergism. Science advances\| PubMed ID: 35061544	2022
Comparison of acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations. Annals of hematology\| PubMed ID: 35083527	2022
Targeting human CALR-mutated MPN progenitors with a neoepitope-directed monoclonal antibody. EMBO reports\| PubMed ID: 35156745	2022
The Cell Type-Specific 5hmC Landscape and Dynamics of Healthy Human Hematopoiesis and TET2-Mutant Preleukemia. Blood cancer discovery\| PubMed ID: 35532363	2022
Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability. Cancer discovery\| PubMed ID: 36355448	2023
Thrombopoietin-independent Megakaryocyte Differentiation of Hematopoietic Progenitor Cells from Patients with Myeloproliferative Neoplasms. Bio-protocol\| PubMed ID: 36789162	2023
Human gene-engineered calreticulin mutant stem cells recapitulate MPN hallmarks and identify targetable vulnerabilities. Leukemia\| PubMed ID: 36813992	2023